CIK 0000727510
- Non-accelerated filer
- Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222372868
- Phone
- +1 630-874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-07-01 | MICATI VICTOR P Director | Option exercise | +1,255 | 16,853 | ||
| 2008-07-01 | MICATI VICTOR P Director | Option exercise · Restricted Stock Units | −1,255 | 0 | ||
| 2008-07-01 | ANDO GORAN Director | Grant or award | +10,417 | 15,598 | ||
| 2008-07-01 | ANDO GORAN Director | Option exercise | +1,255 | 16,853 | ||
| 2008-07-01 | ANDO GORAN Director | Option exercise · Restricted Stock Units | −1,255 | 0 | ||
| 2008-07-01 | SALISBURY ROBERT C Director | Grant or award | +10,417 | 19,629 | ||
| 2008-07-01 | SALISBURY ROBERT C Director | Option exercise | +1,255 | 20,884 | ||
| 2008-07-01 | SALISBURY ROBERT C Director | Option exercise | +3,172 | 24,056 | ||
| 2008-07-01 | SALISBURY ROBERT C Director | Option exercise · Restricted Stock Units | −1,255 | 0 | ||
| 2008-05-22 | Geltosky John Director | Grant or award | +8,343 | $8.99 | $75K | 8,343 |
| 2008-05-22 | Geltosky John Director | Grant or award · Stock Option (right to buy) | +22,930 | 22,930 | ||
| 2008-05-12 | TOOMAN CRAIG A Exec VP Finance, CFO | Option exercise | +4,500 | 116,122 | ||
| 2008-05-12 | TOOMAN CRAIG A Exec VP Finance, CFO | Option exercise · Restricted Stock Units | −4,500 | 10,500 | ||
| 2008-05-12 | Renfro Phillip M Director | Option exercise | +15,000 | $7.40 | $111K | 15,024 |
| 2008-05-12 | Renfro Phillip M Director | Sale | −15,000 | $9.49 | $142K | 24 |
| 2008-05-12 | Renfro Phillip M Director | Option exercise · Stock Option (Right to Buy) | −15,000 | |||
| 2008-05-12 | del Campo Ralph EVP - Technical Operations | Option exercise | +4,500 | 121,156.14 | ||
| 2008-05-12 | del Campo Ralph EVP - Technical Operations | Option exercise · Restricted Stock Units | −4,500 | 10,500 | ||
| 2008-05-12 | Davit Paul Stephen Exec. Vice Pres. HR | Option exercise | +4,500 | 57,603.17 | ||
| 2008-05-12 | Davit Paul Stephen Exec. Vice Pres. HR | Option exercise · Restricted Stock Units | −4,500 | 10,500 |
Page 24 of 25 · 488 trades